New Tube-Feeding device aims to make daily life easier
NCT ID NCT06173063
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new device called Mobility+ for people who need daily tube feeding. The goal was to see if the device is safe and effective, and if it improves quality of life. 19 adults with a feeding tube used the device and recorded their experiences.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
19 people
The number who actually took part.
- Started
-
Nov 2023
- Finished
-
Nov 2024
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Participants with Gastrostomy (G) tube or Jejunostomy (J) tubes * Participant must require enteral tube feeding every day, as determined at the time of study enrolment * Participant must use commercially available enteral formula with standard enteral feeding system(s) (gravity bag, bolus, pump or combination(s)), for some or all of their tube feeds, for daytime or day and night-time feeding * Participant must be EN dependent i.e., 500 ml minimum daily feed intake from EN * Participants must be able to swap from current system to Mobility+ for a minimum of two daily feeds per day for duration of study (Study days 1 -14) * Participant must be \>= 18 to reflect the subset of the intended use population being evaluated * Participant must be willing to participate in the study and provide consent). * Participants must have been on an enteral feeding regime for a minimum of 10 weeks * Participants clinical functional capacity is adequate as determined by operator clinical judgement, to enable them to participate fully in the study * Participants are suitable candidates for using Mobility+ as determined by operator clinical judgement on participant enteral feeding needs (as per prescription) and alignment with Mobility+ Flow Rate Guide Exclusion Criteria: * Participants who do not use commercially available enteral formula for some or all their formula needs * Participants unable/unwilling to provide consent * Participants whose enteral feeding needs do not match the offering of the Mobility+, as determined by operator clinical judgement * Participants who have inadequate clinical functional capacity, as determined by operator clinical judgement to participate fully in the study e.g. neuromuscular or neurodegenerative disorders, or developmental delay * Participants with very limited mobility, as determined by operator clinical opinion
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Enteral feeding are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.